Eloise Chapman-Davis

6PUBLICATIONS
77CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 26, 2026
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.

|Jul 29, 2024
Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer.

Tito A Sandoval, Camilla Salvagno, Chang-Suk Chae

|Jul 29, 2020
Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center.

Eloise Chapman-Davis, Zhen Ni Zhou, Jessica C Fields

|Feb 12, 2019
Role of adjuvant chemotherapy in the management of non-granulosa cell ovarian sex cord-stromal tumors.

Dimitrios Nasioudis, Theofano Orfanelli, Melissa K Frey

|Aug 01, 2017
Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?

Dimitrios Nasioudis, Eloise Chapman-Davis, Melissa K Frey

|May 26, 2017
Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma.

Dimitrios Nasioudis, Eloise Chapman-Davis, Melissa Frey

Pageof 1

Frequent Collaborators

5 joint publications

Melissa K Frey

4 joint publications

Kevin Holcomb

3 joint publications

Dimitrios Nasioudis

2 joint publications

Steven S Witkin